This expression was also significantly superior to adjacent normal colon crypts (p < 0.001), and was confirmed during an ex vivo colonoscopy prodecure performed in 14 mices, by the use of a cetuximab (anti-EGFR)-tracer that could clearly delineate all colorectal adenomas. The gene discussed is EGFR; the disease is colorectal adenoma.